Trials / Completed
CompletedNCT00281554
Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation
A Phase 3, Multi-Center, Open Label, Safety Study of RSD1235 in Subjects With Atrial Fibrillation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 254 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to determine the safety of RSD1235 in patients with atrial fibrillation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RSD1235 | IV |
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2007-01-01
- Completion
- 2007-01-01
- First posted
- 2006-01-25
- Last updated
- 2008-04-03
Locations
40 sites across 6 countries: United States, Argentina, Canada, Denmark, South Africa, Sweden
Source: ClinicalTrials.gov record NCT00281554. Inclusion in this directory is not an endorsement.